Browse MAU2

Summary
SymbolMAU2
NameMAU2 sister chromatid cohesion factor
Aliases MGC75361; mau-2; MAU2L; SCC4; sister chromatid cohesion 4; KIAA0892; MAU2 chromatid cohesion factor homolog ......
Chromosomal Location19p13.11
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Basic function annotation.
> Subcellular Location, Domain and Function
> Gene Ontology
> KEGG and Reactome Pathway
> Subcellular Location, Domain and Function
 
Subcellular Location Nucleus, nucleoplasm Nucleus Chromosome Note=Binds to chromatin from the end of mitosis until prophase.
Domain PF10345 Cohesin loading factor
Function

Plays an important role in the loading of the cohesin complex on to DNA. Forms a heterodimeric complex (also known as cohesin loading complex) with NIPBL/SCC2 which mediates the loading of the cohesin complex onto chromatin (PubMed:28167679, PubMed:22628566). Plays a role in sister chromatid cohesion and normal progression through prometaphase (PubMed:16802858, PubMed:16682347).

> Gene Ontology
 
Biological Process GO:0000070 mitotic sister chromatid segregation
GO:0000819 sister chromatid segregation
GO:0007059 chromosome segregation
GO:0007062 sister chromatid cohesion
GO:0007064 mitotic sister chromatid cohesion
GO:0007067 mitotic nuclear division
GO:0034086 maintenance of sister chromatid cohesion
GO:0034088 maintenance of mitotic sister chromatid cohesion
GO:0098813 nuclear chromosome segregation
Molecular Function GO:0047485 protein N-terminus binding
Cellular Component GO:0000785 chromatin
GO:0032116 SMC loading complex
> KEGG and Reactome Pathway
 
KEGG -
Reactome R-HSA-1640170: Cell Cycle
R-HSA-69278: Cell Cycle, Mitotic
R-HSA-2470946: Cohesin Loading onto Chromatin
R-HSA-68886: M Phase
R-HSA-68884: Mitotic Telophase/Cytokinesis
Summary
SymbolMAU2
NameMAU2 sister chromatid cohesion factor
Aliases MGC75361; mau-2; MAU2L; SCC4; sister chromatid cohesion 4; KIAA0892; MAU2 chromatid cohesion factor homolog ......
Chromosomal Location19p13.11
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Literatures that report relations between MAU2 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells.
> Text Mining
 

There is no record.

Summary
SymbolMAU2
NameMAU2 sister chromatid cohesion factor
Aliases MGC75361; mau-2; MAU2L; SCC4; sister chromatid cohesion 4; KIAA0892; MAU2 chromatid cohesion factor homolog ......
Chromosomal Location19p13.11
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets.
> High-throughput Screening
  Statistical results of MAU2 in screening data sets for detecting immune reponses.
PMID Screening System Cancer Type Cell Line Data Set Statistical Results Relation to immunity
29301958CRISPR-Cas9 melanomaB16F10Pmel-1 T cell NA/NS NA/NS
29301958CRISPR-Cas9 melanomaB16F10OT-1 T cell NA/NS NA/NS
28783722CRISPR-Cas9 melanomaMel6242CT-CRISPR Second most enriched score: 0.71 Sensitive to T cell-mediated killing
28723893CRISPR-Cas9 melanomaB16GVAX+Anti-PD1 NA/NS NA/NS
28723893CRISPR-Cas9 melanomaB16GVAX NA/NS NA/NS
25691366RNAiBreast cancerMCF7Luc-CTL assay NA/NS NA/NS
24476824shRNAmelanomaB16Primary screen NA/NS NA/NS
24476824shRNAmelanomaB16Secondary screen NA/NS NA/NS
Summary
SymbolMAU2
NameMAU2 sister chromatid cohesion factor
Aliases MGC75361; mau-2; MAU2L; SCC4; sister chromatid cohesion 4; KIAA0892; MAU2 chromatid cohesion factor homolog ......
Chromosomal Location19p13.11
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets.
> Expression difference between responders and non-responders
> Mutation difference between responders and non-responders
> Expression difference between responders and non-responders
 
Points in the above scatter plot represent the expression difference of MAU2 in various data sets.
No PMID Cancer type Group Drug # Res # NRes Log2 (Fold Change) P value Anno
126997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)1412-0.1290.439
226997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)65-0.4040.821
326997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)870.0720.955
428552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 9160.3190.312
528552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590.3330.874
628552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470.3030.911
729033130MelanomaallAnti-PD-1 (nivolumab) 26230.0410.896
829033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 15110.010.995
929033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 11120.0720.967
1029301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 480.4210.727
1129301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 2001
1229301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 280.9580.576
1329443960Urothelial cancerallAnti-PD-L1 (atezolizumab) 682300.0040.945
> Mutation difference between responders and non-responders
 
Points in the above scatter plot represent the mutation difference of MAU2 in various data sets.
No PMID Cancer type Group Drug # Res # NRes % Mut/Res % Mut/NRes % Diff (R vs NR) Pval Anno
125765070Non-small cell lung cancer (NSCLC)allAnti-PD-1 (pembrolizumab) 14170001
225765070Non-small cell lung cancer (NSCLC)smokingAnti-PD-1 (pembrolizumab) 1030001
325765070Non-small cell lung cancer (NSCLC)non-smokingAnti-PD-1 (pembrolizumab) 4140001
426359337MelanomaallAnti-CTLA-4 (ipilimumab) 27737.407.40.0709
526359337MelanomaBRAFiAnti-CTLA-4 (ipilimumab) 0140001
626359337Melanomanon-BRAFiAnti-CTLA-4 (ipilimumab) 27597.407.40.096
726997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)21170001
826997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)860001
926997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)13110001
1028552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 91606.2-6.21
1128552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 59011.1-11.11
1228552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470001
1329033130MelanomaallAnti-PD-1 (nivolumab) 382703.7-3.70.415
1429033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 221307.7-7.70.371
1529033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 16140001
1629301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 11130001
1729301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 610001
1829301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 5120001
Summary
SymbolMAU2
NameMAU2 sister chromatid cohesion factor
Aliases MGC75361; mau-2; MAU2L; SCC4; sister chromatid cohesion 4; KIAA0892; MAU2 chromatid cohesion factor homolog ......
Chromosomal Location19p13.11
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of MAU2. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene.
> Lymphocyte
 
Summary
SymbolMAU2
NameMAU2 sister chromatid cohesion factor
Aliases MGC75361; mau-2; MAU2L; SCC4; sister chromatid cohesion 4; KIAA0892; MAU2 chromatid cohesion factor homolog ......
Chromosomal Location19p13.11
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of MAU2. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by MAU2.
> Immunoinhibitor
> Immunostimulator
> MHC molecule
> Immunoinhibitor
 
> Immunostimulator
 
> MHC molecule
 
Summary
SymbolMAU2
NameMAU2 sister chromatid cohesion factor
Aliases MGC75361; mau-2; MAU2L; SCC4; sister chromatid cohesion 4; KIAA0892; MAU2 chromatid cohesion factor homolog ......
Chromosomal Location19p13.11
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of MAU2. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene.
> Chemokine
> Receptor
> Chemokine
 
> Receptor
 
Summary
SymbolMAU2
NameMAU2 sister chromatid cohesion factor
Aliases MGC75361; mau-2; MAU2L; SCC4; sister chromatid cohesion 4; KIAA0892; MAU2 chromatid cohesion factor homolog ......
Chromosomal Location19p13.11
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Distribution of MAU2 expression across immune and molecular subtypes.
> Immune subtype
> Molecular subtype
> Immune subtype
 
> Molecular subtype
 
Summary
SymbolMAU2
NameMAU2 sister chromatid cohesion factor
Aliases MGC75361; mau-2; MAU2L; SCC4; sister chromatid cohesion 4; KIAA0892; MAU2 chromatid cohesion factor homolog ......
Chromosomal Location19p13.11
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Associations between MAU2 and clinical features.
> Overall survival analysis
> Cancer stage
> Tumor grade
> Overall survival
 
> Stage
 
> Grade
 
Summary
SymbolMAU2
NameMAU2 sister chromatid cohesion factor
Aliases MGC75361; mau-2; MAU2L; SCC4; sister chromatid cohesion 4; KIAA0892; MAU2 chromatid cohesion factor homolog ......
Chromosomal Location19p13.11
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Drugs targeting MAU2 collected from DrugBank database.
> Drugs from DrugBank database
 

There is no record.